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Methods: A literature search was systematically conducted to evaluate the significance of the learning curve on
complications in kidney transplantation. Meta-analyses of the effect of the learning curve on warm ischemicAim: To assess the impact of the learning curve of kidney transplantation on operative and postoperative compli-
time, total operating time (TOT), vascular and urological complications, postoperative bleeding, lymphocele
and infection.
Results: Nine studies met the inclusion criteria and 2762 patients were included in the present meta-analyses.
Surgeons at the beginning of the learning curve were found to have longer TOT (mean difference 41.77 (95%
CI: 4.48–79.06; P = .03) and more urological complications (risk ratio 3.93; 95% CI: 1.87–8.25; P < .01). No dif-
ferences were seen in warm ischemic time, postoperative bleeding, lymphocele, and vascular complications.
Conclusion: Surgeons at the beginning of their learning curve have a longer TOT and more urological complica-
tions, without an effect on postoperative bleeding, lymphocele, infection and vascular complications. For inter-
pretation of the outcomes, the quality and sample size of the evidence should be taken into consideration.
© 2020 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://
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Kidney transplantation is the treatment of choice for patients with
end-stage renal failure. [1] With 90.000 surgeries performed world-
wide, kidney transplantation has become a substantial part of modern
medicine. [2] Despite wide-ranging precautions to ensure patient
safety, medical errors are still a source of complications and hospital
costs. [3,4] Over the years, surgical techniques in kidney transplantation
have changed substantially to improve quality of care and minimise
complications. The learning curve is particularly important in surgery
where a constant stream of new skills must be acquired safely and effi-
ciently. Higher caseload proved better outcomes in various other fields
of surgery such as oncological surgery, cardiothoracic surgery. [5,6]
However, little is known about the impact of the learning curve in kid-
ney transplantation, its effect on complications and patient outcome.
Data on learning associated morbidity and mortality is needed to de-
velop structured training programs and increase patient safety during
these learning curves. Our aim is to systematically search the literature
and analyse the impact of the learning curve of kidney transplantation
and to assess its effect on intra- and postoperative complications.
2. Methods
The design of this systematic review was based on the criteria and
guidelines mentioned in the Preferred Reporting Items for Systematic
Reviews (PRISMA). [7] A systematic literature search of Embase,
Medline Epub (Ovid), Cochrane Central, Web of Science and Google
Scholar was constructed on June 14, 2019, to identify all studies on
learning curve in kidney transplantation. The queries were constructed
using suitable terms concerning surgeon experience, the surgical learn-
ing curve and kidney transplantation and. (See appendix A).
Titles, abstract and full-text articles were screened independently by
two investigators. Predefined exclusion criteria included studies focus-
ing on human subjects under the age of 18 or animals or in vitro-
studies, specific types of articles (e.g. conference abstracts, letters to
the editor, replies, editorials, case reports, guidelines and reviews). Du-
plicate articles were removed.
Articles were screened on relevance based on the title and abstract.
The remaining studies were assessed for relevance by evaluation of
full-text articles. The reference lists of the included studies were exam-
ined to identify the studies that might have been missed during the
search. These articles were included in this systematic review.
2.1. Data extraction
The data extractionwas performed independently by two reviewers.
Study parameters collected for data includedwere:warm ischemic time
(WIT), total operating time (TOT), urological complications, postopera-
tive bleeding, infection, lymphocele and vascular complications.
2.2. Categories
To compare the results of the studies, two groups were created: less
experienced and well experienced surgeons. Surgeons in the less expe-
rienced grouphad performedbetween 0 and 30kidney transplantations
and those in the well experienced group had completed over 30 kidney
transplantations. The cut off of 30 was chosen as the majority of studies
published on this subject refers to this number.2.3. Quality of evidence assessment
Quality assessment was performed using an adjusted version of the
Newcastle-Ottawa Scale for observational studies (NOS). [8] The in-
cluded articles were scored in three different sections namely the selec-
tion process, the comparison and the outcome. For each section,
questions regarding quality were answered and points were awarded
if the criteria were met. The maximum amount of points that could be
obtained was nine. Studies with seven or more points were considered
to be of good quality. Studies with four to six were scored as moderate
quality and studieswith three or less pointswere scored as poor quality.
2.4. Statistical analyses
We performed meta-analysis on six outcomes (WIT, TOT, urological
complications, postoperative bleeding, lymphocele and vascular com-
plications) using Review Manager 5.3. The pooled risk ratios (RR) and
95% confidence intervals (CI) were assessed using the DerSimonian-
Laird method, a binary random effects method. A P-value below 0.05
was considered statistically significant. Potential variancedue to hetero-
geneity between studies was estimated by the statistic I2 whichwas de-
fined as low (25%), moderate (50%) or high (75%).
3. Results
3.1. Study selection
The PRISMA flow diagram of articles included in the present review
is depicted in Fig. 1. A total of 1090 potentially eligible articles were
identified. Nine articles met our inclusion criteria and were included
in this systematic review. [9–17] The baseline characteristics of all
nine included studies are shown in Table 1. The results of the intra-
and postoperative complications are showcased in Table 2. Six studies
provided data for meta-analysis. [9,13–17]
3.2. Quality assessment
The results of the quality assessment are shown in Table 3. Three
studieswere rated as good quality. [13,15,17] The quality of the remain-
ing six studies was considered moderate. [9–12,14,16]
3.3. Warm ischemic time
Four studies measured warm ischemic time (WIT) including 3 stud-
ies with quantitative data (Fig. 2). [9,13,14] A total of 916 patients were
included of which 55.6% (509/916) in the less experienced group and
44.4% (407/916) in the experienced group. The pooled mean difference
inminuteswas 8.20 (95% CI:−1.80, 18.20; P= .11) and showed no sig-
nificant lower WIT in the experienced group. The I2 heterogeneity was
99% with a P-value of less than 0.01.
3.4. Total operative time
Four studiesmeasured total operative time (TOT) including2 studies
with quantitative data (Fig. 3). [9,14] A total of 497 patients were in-
cluded of which 84.9% (422/497) in the less experienced group and
15.1% (75/497) in the experienced group. The mean difference in mi-
nutes was significant shorter in the experienced group 41.77 (95% CI:
Fig. 1. Flowchart of search strategy and selection process.
Table 1
Characteristics of included studies.
Author Thomas et al [9] Wolff et al
[10]
Weng et al [11] Oitchayomi
et al [12]
Cash et al [13] Fechner
et al [14]
Seow et al
[15]
Dlugosz
et al [16]
Kulu et al [17]
Year of
publication
2013 2014 2015 2014 2011 2012 2012 1999 2018
Country Germany Switzerland Taiwan France Germany Germany United
Kingdom
Poland Germany
Mean volume
of KTx per
year
61 41 222a 105 27 15 107 20 86
Number of
patients
184 1496 1779 738 484 392 322 225 1462
Number of
surgeons
16 33 142 90 13 18 – 143 –
Number of
groups
4 8 2 3 2 5 2 2 5
Division of
groups
Trainees, low-experienced:
30 supervised interventions,
medium: 30 unsupervised
interventions,
high-experienced
Number of
surgeries
divided per
10
low-volume < 33
transplant,
medium/high
volume > 33
Juniors 1,
Juniors 2,
Seniors
Inexperienced>30
surgeries,
experienced >30
surgeries
Number of
surgeries
divided
per 10
Trainees vs
trained
Learning
group vs
seniors
Inexperienced
<25,
experienced
>25
Follow-up time
(in months)
3 12 120 60 12 12 6 36 3
Period of
follow-up
2010–2012 1962–2003 1999–2007 2006–2012 1988–2005 1985–2010 1998–2001 1985–1995 2000–2016
Living or
deceased
donors
Deceased donors 73%
deceased
donors
Deceased donors – Deceased donors Deceased
donors
Deceased
donors
Deceased
donors
66% deceased
donors
Ureterovesical
anastomosis,
with or
without
stent
– Lich
Gregoir,
with stent
– Lich
Gregoir,
with stent
Politano
Leadbetter, with
stent
Lich
Gregoir,
with stent
Lich
Gregoir,
with stent
b
– Lich Gregoir,
with stent
Mean age
recipients
57 47 – 53.6 47.7 48 – – 48.5
Mean age
donors
58 41 – 56.6 48.7 42.5 – – 51.2
a Nationwide study in which 35 hospitals participated.
b Stent was added in January 2000.
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Table 2
Results of intra- and postoperative complications.
Author Thomas et al [9] Wolff
et al
[10]
Weng
et al
[11]
Oitchayomi et al
[12]
Cash et al [13] Fechner et al [14] Seow et al [15] Dlugosz
et al
[16]
Kulu et al [17]
Warm ischemic
time in minutes
Significantly lower
in experienced
surgeons
– – Significantly lower
in experienced
surgeons
N·Sa Significantly lower
in most
experienced group
– – –
Total operative
time in minutes
Significantly lower
in experienced
surgeons
– – Significantly lower
in experienced
surgeons
– Significantly lower
in most
experienced group
Significantly lower
in experienced
surgeons
Lymphocele N·S N.S. – – N.S. N.S. N.S. – –
Urological
complications
N.S. – – N.S. Significantly lower
in experienced
surgeons
N.S Significantly lower
in experienced
surgeons
N.S. –
Vascular
complications
N.S. N.S. – N.S. N.S. N.S. N.S. – Significantly lower
in experienced
surgeons
Post-operative
bleeding
N.S. – – – N.S. N.S. N.S. –
Wound infection N.S. – – – – N.S. – –
a N.S. = not significant.
Table 3
Quality assessment of included studies.
Author Selection Comparability Outcome Total Quality
The study population is
a representative of the
population undergoing
kidney transplantation
(*)
The study
population
received a
kidney
from living and
deceased donor.
(*)
Were
surgeons
divided
in
two
groups?
(*)
Correction
for case
selection
was done.
(*)
Assessment of
outcome was from
independent blind
assessment or
record
linkage. (*)
Quantative
data of
parameters
was
available.
(**)
Follow-up
was long
enough for
outcomes
to
occur. (*)
Was loss of
follow-up
after
baseline
less
than 20%?
(*)
1 Thomas et al [9] * – – – * ** * * 6 Moderate
2 Wolff et al [10] * * – * * – * * 6 Moderate
3 Weng et al [11] * – * – * – * * 5 Moderate
4 Oitchayomi et al
[12]
* – – – * – * * 4 Moderate
5 Cash et al [13] * – * – * ** * * 7 Good
6 Fechner et al [14] * – – – * ** * * 6 Moderate
7 Seow et al [15] * – * – * ** * * 7 Good
8 Dlugosz et al [16] * – – – * ** * * 6 Moderate
9 Kulu et al [17] * * – – * ** * * 7 Good
Fig. 2.Meta-analysis of warm ischemic time.
Fig. 3. Meta-analysis of total operative time.
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Fig. 4.Meta-analysis of urological complications.
5L. Outmani et al. / Transplantation Reviews 34 (2020) 1005644.48–79.06; P = .03). The I2 heterogeneity was 63% with a P-value of
0.10.
3.5. Urological complications
Six studies implemented urological complications as outcome in-
cluding 4 studies with quantitative data (Fig. 4). [13–16] A total of
1300 patients were included of which 57.4% (746/1300) in the less ex-
perienced group and 42.6% (554/1300) in the experienced group. The
risk of an urological complication was almost 4 times higher in the
less experienced group RR 3.93 (95% CI: 1.87–8.25; P= .01). The I2 het-
erogeneity was 15% with a P-value of 0.32.
3.6. Postoperative bleeding
Four studies measured postoperative bleeding including 2 studies
with quantitative data (Fig. 5). [13,14]A total of 827 patients were in-
cluded of which 56.2% (465/827) in the less experienced group and
43.8% (362/827) in the high experienced group. The pooled RR showed
no significant higher postoperative bleeding in the less experienced
group RR 0.97 (95% CI:0.45–2.12; P = .94). The I2 heterogeneity was
0% with a P-value of 0.89.
3.7. Infection
Two studies reported that there was no difference in infection rate
between the experienced and less experienced groups. [9,15]Fig. 5.Meta-analysis of po
Fig. 6.Meta-analysis3.8. Lymphocele
Five studies measured lymphocele including 2 studies with quanti-
tative data (Fig. 6). [13,14] A total of 827 patients were included of
which 56.2% (465/827) in the less experienced group and 43.8% (362/
827) in the high experienced group. The pooled RRwas not significantly
different between experienced and less experienced surgeonswith a RR
0.87 (95% CI: 0.43–1.73; P= .68). The I2 heterogeneity was 0%with a P-
value of 0.46.
3.9. Vascular complications
Five studies measured vascular complications including 3 studies
with quantitative data (Fig. 7). [13,14,17] A total of 2289 patients
were included of which 45.3% (1038/2289) in the less experienced
group and 54.9% (1251/2289) in the high experienced group. The
pooled RR showed no statistical significant difference for risk of vascular
complications with a RR 2.31 (95% CI: 0.55–10.78; P = .29). The I2 het-
erogeneity was 0% with a P-value of 0.02.
4. Discussion
Our systematic review and meta-analysis revealed that experienced
surgeons had a shorter TOT and lower risk of urological complications.
This analysis uses case volume as a surrogate marker for experience.
Prior studies in other disciplines have mentioned the importance ofstoperative bleeding.
of lymphocele.
Fig. 7.Meta-analysis of vascular complications.
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case volume and improved outcomes. [5,6]
Kulu et al. described a correlation between experience and the pre-
dictive probability of developing vascular and haemorrhagic complica-
tions after kidney transplantation. [17] Their analysis revealed 26 as
the best cut off number of previous KTx's to decrease the predicted
probability of vascular and haemorrhagic complications. However,
using case volume as a surrogate marker for experience does not take
into account the technical skill level of individual surgeons. Heylen
et al. examined an alternative measure of surgical skill using anastomo-
sis time and demonstrated a correlation with kidney allograft function,
suggesting that individual technical skill is a more accurate measure for
surgeon related outcome instead of case volume. [18]
It is unclearwhether short operative duration actually is a goodmea-
surement of the quality of surgery. [19] In a systematic reviewpublished
by Cheng et al. the association between operative duration and compli-
cations across several surgical specialties was review. [20] They con-
cluded that increased operative duration was associated with a
statistically significant increase in postoperative complications in both
general surgery and urology. An increment of 30 min increased the
risk of complications by 14% (P < .001).
However, in kidney transplantation, TOT is not as important as the
anastomotic time. Three studies observed a longer WIT in less experi-
enced surgeons compared to experienced surgeons. [9,12,14] This dif-
ference however, is not significant when all data is pooled. Transplant
surgeons are advised to keepWIT as short as possible due to the damage
longerWITmay have on kidney allografts. LongerWIT increases the risk
of primary non-function (PNF) and is associated with delayed graft
function (DGF) and acute tubular necrosis (ATN). [18,21] Heylen et al.
found in an analysis of 669 kidney transplants that WIT above 35 min
is associated with lower allograft function up to three years after trans-
plantation (P< .001). [18] At one and two year after transplantation, al-
lografts with WIT longer than 35 min had significantly more interstitial
fibrosis and tubular atrophy (IFTA) (p = .002), which suggest that lon-
ger WIT also has an impact on chronic allograft injury. In two included
studies, the mean WIT in both experienced and less experienced sur-
geons was well above the threshold of 35 min. [13,14]
Cash et al. and Seow et al. reported a higher risk of urological compli-
cations in less experienced surgeons. [13,15] This difference could be
explained by their technique for the ureterovesical anastomosis. Cash
et al. used the Politano Leadbetter technique. Previous studies have
shown that this intravesical technique is more susceptible to complica-
tions compared to other techniques. [22] A systematic review by Alberts
et al. concluded that the Lich-Gregoir ureterovesical anastomotic tech-
nique compared to the Politano Leadbetter technique results in signifi-
cantly less postoperative urological complications. [23] The difference
in urological complications could also be explained by the lack of a ure-
teric stent. Seow et al. state that the use of a ureteric stent was intro-
duced halfway through their study and that routinely use of a stent
had drastically reduced the urological complication rate. [15] This is in
line with other studies that concluded that the use of ureteric stents re-
sults in less urological complications compared to no stent use. [24–26]
A third explanation for the increase in urological complications is thatmost kidney transplants are carried out by vascular or general surgeons.
They have less experience in performing ureterovesical anastomoses
compared to vascular anastomoses. That means that the learning
curve observed in this study reflects the true learning curve surgeons
go through, when they are trained for kidney transplantations. Consid-
ering that the ureteric anastomosis is the Achilles heel in transplant sur-
gery, senior surgeons are advised to put more emphasis the ureteric
anastomosis while training transplant surgeons. Complication caused
by a poorly performed ureteric anastomosis can lead to decrease graft
function or even graft loss. Less experienced surgeons should only per-
form ureterovesical anastomosis under strict supervision of a senior
surgeon until they have mastered this skill.
Less experienced surgeons have an almost 2.5 folds increased risk of
vascular complications (RR 2.31; 95%CI: 0.55–10.78; P=.29).However,
this RR is not statistically significant. This is probably due to the small
study population and the rare occurrence of vascular complications. As
rare complications have lower statistical power, larger number of pa-
tients are needed to detect significant differences. The same applies
for the incidence of lymphocele post kidney transplantation. These com-
plications rarely occur and are often misclassified or missed as they
often present asymptomatically. [27] One of the surgical causes of lym-
phatic complications is the dissection of renal lymphatic tissue of the
donor kidney either during the organ procurement surgery or during
‘back table’ work. [27] The surgeon performing the transplantation is
often not the surgeon who procured the organ, which makes it hard
to attribute this complication to the surgeon performing the transplan-
tation and should not be used as a measure to quantify surgical skills.
The majority of the included studies were performed in low-
volume hospitals. There is evidence that hospital volume may influ-
ence outcome in transplantation. Several studies have shown that
higher hospital volume is associated with improved patient outcome
and reduced postoperative complications. [13,28,29] This is possibly
due to logistical advantage of centralizing specialized care. The
whole medical care including nephrologists, surgeons, and OR-
personal are more familiar with kidney transplant recipients. The
medical process will be better organized, which will reduce human
mistakes and medical errors.
Our study has several limitations.We included only nine articles due
to the fact that a few studies have published on the learning curve in
kidney transplantation. There was a lot of heterogeneity between the
articles that were included. This heterogeneity was regarding the out-
come and complications and the way surgeon were divided into differ-
ent groups. We could not collect any information on the postoperative
kidney function and the primary non function and delayed graft func-
tion rate. Another risk of bias is that more complex cases are assigned
to experienced surgeons. One of the most important factor of surgical
complications are patient characteristics. [1,30] Surgeries onmore com-
plex patients have therefor a higher risk of complications. Most studies
included in this systematic review did not correct for case selection.
In conclusion, less experienced surgeons have a longer TOT and
higher urological complications risk, possible due to the effect of the
learning curve. The learning curve in kidney transplantation seems not
to affect the risk of postoperative bleeding, lymphocele, infection and
7L. Outmani et al. / Transplantation Reviews 34 (2020) 100564vascular complication.Well performed studies are needed as risk of bias
was high and quality of the reports are moderate.
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